bluebird bio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
bluebird bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2012 to Q4 2023.
  • bluebird bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $1.19B, a 6.55% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.19B +$73.3M +6.55% Dec 31, 2023 10-K 2024-09-13
Q4 2022 $1.12B +$92.1M +8.97% Dec 31, 2022 10-K 2024-09-13
Q4 2021 $1.03B +$183M +21.7% Dec 31, 2021 10-K 2023-03-29
Q4 2020 $843M +$98.8M +13.3% Dec 31, 2020 10-K 2022-03-04
Q4 2019 $745M +$201M +37% Dec 31, 2019 10-K 2021-02-23
Q4 2018 $543M +$170M +45.7% Dec 31, 2018 10-K 2020-02-18
Q3 2018 $7.9M Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $7.9M Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $7.9M Mar 31, 2018 10-Q 2018-05-02
Q4 2017 $373M +$127M +51.6% Dec 31, 2017 10-K 2019-02-21
Q4 2016 $246M +$105M +74.8% Dec 31, 2016 10-K 2018-02-21
Q4 2015 $141M +$75.5M +116% Dec 31, 2015 10-K 2017-02-22
Q4 2014 $65.3M +$24.7M +61% Dec 31, 2014 10-K 2016-02-25
Q4 2013 $40.6M +$11.1M +37.8% Dec 31, 2013 10-K 2015-02-25
Q4 2012 $29.4M Dec 31, 2012 10-K 2014-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.